Use and abuse of faecal occult blood tests in an acute hospital inpatient setting

Internal Medicine Journal

Volumn 40, Issue 2, 2010, Pages 107-111

  Friedman, Antony ^a,b   Chan, A ^b   Chin, L C ^b   Deen, A ^b   Hammerschlag, G ^b   Lee, M ^b   Liddell, J ^b   Loh, K ^b   Moore, E ^b   Ng, J ^b   Gibson, P R ^b  

^a BOX HILL HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Clinical practice; Faecal test; Gastrointestinal bleeding

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DIPYRIDAMOLE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CANCER SCREENING; CHILD; CLINICAL DECISION MAKING; COLONOSCOPY; COLORECTAL CANCER; COST BENEFIT ANALYSIS; DIARRHEA; DIET RESTRICTION; ENDOSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HOSPITAL PATIENT; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 77749304909     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02149.x     Document Type: Article

References (8)

1. Young GP, Cole S. New stool screening tests for colorectal cancer. Digestion 2007 76 : 26 33.
2. Li S, Wang H, Hu J, Li N, Liu Y, Wu Z et al. New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients. Int J Cancer 2006 118 : 3078 3083.
3. Sinatra MA, St John DJ, Young GP. Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable. Clin Chem 1999 45 : 123 126.
4. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. JAMA 2000 284 : 1247 1255.
5. Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med 2003 163 : 59 64.
6. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993 328 : 1365 1371.
7. Hardcastle JD, Chamberlain JO, Robinson MHE, Amar SS, Balfour TW et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996 348 : 1472 1476.
8. Sharma VK, Komanduri S, Nayyar S, Headly A, Modlinger P, Metz D et al. An audit of the utility of in-patient fecal occult blood testing. Am J Gastroenterol 2001 96 : 1256 1260.